CD30 Imaging in Diffuse Large B-cell Lymphoma

NCT06186986 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell-lymphoma

Interventions

DRUG: Brentuximab vedotin

Sponsor

University Medical Center Groningen

Collaborators

[object Object]